http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2012507030-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-26 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5091 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6893 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-533 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-543 |
| filingDate | 2009-10-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2012-03-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2012507030-A |
| titleOfInvention | Method and kit for rapidly determining patients at high risk of death during severe sepsis and septic shock |
| abstract | The present invention provides methods and kits for initially assessing the risk of death for patients with severe sepsis with two organ dysfunctions, such as patients with septic shock, and to assist in making treatment decisions. The present invention is based on the measurement of the level of S100A8 / A9 complex in plasma. This is because a level of S100A8 / A9 higher than a predetermined threshold indicates a bad prognosis, and a level of S100A8 / A9 lower than a predetermined threshold indicates a good prognosis. [Selection] Figure 1 |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2020162615-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101929772-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2017514459-A |
| priorityDate | 2008-10-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 59.